Skip to main content

Advertisement

SpringerLink
Log in

Pediatric multiple sclerosis

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

The onset of multiple sclerosis (MS) in childhood is being increasingly recognized. Despite this, there currently exist several barriers to the prompt diagnosis of MS in children. Many clinicians view MS as an exclusively adult-onset disease, and thus they may not entertain the diagnosis in a child. Also, the clinical and radiographic criteria for the diagnosis of MS have not been validated in a pediatric MS population. The available literature, as well as experience gained in a dedicated pediatric MS clinic, is used here to describe features of pediatric MS and contrast these with adult MS. The rationale and importance of future studies in pediatric MS is highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Noseworthy J, Lucchinetti C, Rodriguez M, Weinshenker B: Multiple sclerosis. N Engl J Med 2000, 343:938–952. This review summarizes the available literature on MS and provides a clear description of currently proposed etiologic concepts of MS in light of pathobiologic studies.

    Article  PubMed  CAS  Google Scholar 

  2. Duquette P, Murray TJ, Pleines J, et al.: Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr 1987, 111:359–363.

    Article  PubMed  CAS  Google Scholar 

  3. Houzen H, Niino M, Kikuchi S, et al.: The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 2003, 211:49–53.

    PubMed  Google Scholar 

  4. Itoh T, Aizawa H, Hashimoto K, et al.: Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan. J Neurol Sci 2003, 214:7–9.

    Article  PubMed  Google Scholar 

  5. Pugliatti M, Sotgiu S, Rosati G: The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002, 104:182–191. Excellent review of MS prevalence across variable geographic regions.

    Article  PubMed  Google Scholar 

  6. Sadovnick AD, Ebers GC: Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993, 20:17–29.

    PubMed  CAS  Google Scholar 

  7. Barcellos LF, Oksenberg JR, Begovich AB, et al.: HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003, 72:710–716.

    Article  PubMed  CAS  Google Scholar 

  8. Ligers A, Dyment DA, Willer CJ, et al.: Evidence of linkage with HLA-DR in DRB1©15-negative families with multiple sclerosis. Am J Hum Genet 2001, 69:900–903.

    Article  PubMed  CAS  Google Scholar 

  9. Dyment DA, Sadovnick AD, Ebers GC, Sadnovich AD: Genetics of multiple sclerosis. Hum Mol Genet 1997, 6:1693–1698.

    Article  PubMed  CAS  Google Scholar 

  10. Hauser SL, Fleischnick E, Weiner HL, et al.: Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology 1989, 39:275–277.

    PubMed  CAS  Google Scholar 

  11. Allen M, Sandberg-Wollheim M, Sjogren K, et al.: Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994, 39:41–48.

    Article  PubMed  CAS  Google Scholar 

  12. Masterman T, Ligers A, Olsson T, et al.: HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000, 48:211–219.

    Article  PubMed  CAS  Google Scholar 

  13. Sadovnick AD, Dircks A, Ebers GC: Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals. Clin Genet 1999, 56:118–122.

    Article  PubMed  CAS  Google Scholar 

  14. Sadovnick AD, Armstrong H, Rice GP, et al.: A populationbased study of multiple sclerosis in twins: update. Ann Neurol 1993, 33:281–285.

    Article  PubMed  CAS  Google Scholar 

  15. Sadovnick AD, Yee IM, Ebers GC: Factors influencing sib risks for multiple sclerosis. Clin Genet 2000, 58:431–435.

    Article  PubMed  CAS  Google Scholar 

  16. Sadovnick AD, Baird PA, Ward RH: Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988, 29:533–541.

    Article  PubMed  CAS  Google Scholar 

  17. Poser CM, Paty DW, Scheinberg L, et al.: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227–231.

    Article  PubMed  CAS  Google Scholar 

  18. McDonald WI, Compston A, Edan G, et al.: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121–127. This paper outlines the most recent criteria proposed for MS diagnosis, and the first formal criteria in which MRI is incorporated..

    Article  PubMed  CAS  Google Scholar 

  19. Boiko A, Vorobeychik G, Paty D, et al.: Early onset multiple sclerosis: a longitudinal study. Neurology 2002, 59:1006–1010. oThis paper outlines the clinical features and outcome of one of the largest cohorts of pediatric-onset MS.

    Article  PubMed  CAS  Google Scholar 

  20. Ruggieri M, Polizzi A, Pavone L, Grimaldi LM: Multiple sclerosis in children under 6 years of age. Neurology 1999, 53:478–484.

    PubMed  CAS  Google Scholar 

  21. Schwarz S, Mohr A, Knauth M, et al.: Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001, 56:1313–1318.

    PubMed  CAS  Google Scholar 

  22. Tenembaum S, Chamoles N, Fejerman N: Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224–1231. This represents the largest study of pediatric ADEM.

    PubMed  Google Scholar 

  23. Wingerchuk DM: Postinfectious encephalomyelitis. Curr Neurol Neurosci Rep 2003, 3:256–264. This paper provides a scholarly review of postinfectious encephalomyelitis.

    Article  PubMed  Google Scholar 

  24. Dale RC, de Sousa C, Chong WK, et al.: Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000, 123:2407–2422.

    Article  PubMed  Google Scholar 

  25. Morales DS, Siatkowski RM, Howard CW, Warman R: Optic neuritis in children. J Pediatr Ophthalmol Strabismus 2000, 37:254–259.

    PubMed  CAS  Google Scholar 

  26. Riikonen R, Donner M, Erkkila H: Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children. Dev Med Child Neurol 1988, 30:349–359.

    Article  PubMed  CAS  Google Scholar 

  27. Lucchinetti CF, Kiers L, O’Duffy A, et al.: Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 1997, 49:1413–1418.

    PubMed  CAS  Google Scholar 

  28. Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999, 53:1107–1114.

    PubMed  CAS  Google Scholar 

  29. Frohman EM, Goodin DS, Calabresi PA, et al.: The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003, 61:602–611. This a nice review of MRI utility in MS.

    PubMed  CAS  Google Scholar 

  30. McAdam L, Blaser S, Banwell B: Pediatric tumefactive demyelination: case series and review of the literature. Pediatr Neurol 2002, 26:18–25.

    Article  PubMed  Google Scholar 

  31. Wang CH, Walsh K: Multiple ring-enhancing lesions in a child with relapsing multiple sclerosis. J Child Neurol 2002, 17:69–72.

    PubMed  CAS  Google Scholar 

  32. Miller A: Diagnosis of multiple sclerosis. Semin Neurol 1998, 18:309–316.

    PubMed  CAS  Google Scholar 

  33. Gronseth GS, Ashman EJ: Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidencebased review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 54:1720–1725.

    PubMed  CAS  Google Scholar 

  34. Boutin B, Esquivel E, Mayer M, et al.: Multiple sclerosis in children: report of clinical and paraclinical features of 19 cases. Neuropediatrics 1988, 19:118–123.

    PubMed  CAS  Google Scholar 

  35. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343:938–952.

    Article  PubMed  CAS  Google Scholar 

  36. Andersson PB, Goodkin DE: Glucocorticosteroid therapy for multiple sclerosis: a critical review. J Neurol Sci 1998, 160:16–25.

    Article  PubMed  CAS  Google Scholar 

  37. Beck RW, Cleary PA, Trobe JD, et al.: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group [see comments]. N Engl J Med 1993, 329:1764–1769.

    Article  PubMed  CAS  Google Scholar 

  38. Assa A, Watemberg N, Bujanover Y, Lerman-Sagie T: Demyelinative brainstem encephalitis responsive to intravenous immunoglobulin therapy. Pediatrics 1999, 104:301–304.

    Article  PubMed  CAS  Google Scholar 

  39. Sahlas DJ, Miller SP, Guerin M, et al.: Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 2000, 54:1370–1372.

    PubMed  CAS  Google Scholar 

  40. Pradhan S, Gupta RP, Shashank S, Pandey N: Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 1999, 165:56–61.

    Article  PubMed  CAS  Google Scholar 

  41. Sorensen PS, Fazekas F, Lee M: Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis. Eur J Neurol 2002, 9:557–563.

    Article  PubMed  CAS  Google Scholar 

  42. Galetta SL, Markowitz C, Lee AG: Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review. Arch Intern Med 2002, 162:2161–2169. s review details approved MS-targeted therapies and provides an excellent summary of the pivotal studies.

    Article  PubMed  CAS  Google Scholar 

  43. Jacobs LD, Cookfair DL, Rudick RA, et al.: Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) [see comments] [published erratum appears in Ann Neurol 1996 Sep;40(3):480]. Ann Neurol 1996, 39:285–294.

    Article  PubMed  CAS  Google Scholar 

  44. PRISMS: Randomised Double-Blind Placebo-Controlled Study of Interberon beta-1a in Relapsing-Remitting MS. Lancet 2000, 352:1498–1504.

    Google Scholar 

  45. Rudick RA, Fisher E, Lee JC, et al.: Use of the brain parenchymal fraction to measure whole brain atrophy in relapsingremitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999, 53:1698–1704.

    PubMed  CAS  Google Scholar 

  46. Fischer JS, Priore RL, Jacobs LD, et al.: Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 2000, 48:885–892.

    Article  PubMed  CAS  Google Scholar 

  47. Weinstein A, Schwid SI, Schiffer RB, et al.: Neuropsychologic status in multiple sclerosis after treatment with glatiramer acetate (Copaxone). Arch Neurol 1999, 56:319–324.

    Article  PubMed  CAS  Google Scholar 

  48. Waubant E, Hietpas J, Stewart T, et al.: Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 2001, 32:211–213.

    Article  PubMed  CAS  Google Scholar 

  49. Mikaeloff Y, Moreau T, Debouverie M, et al.: Interferonbeta treatment in patients with childhood-onset multiple sclerosis. J Pediatr 2001, 139:443–446.

    Article  PubMed  CAS  Google Scholar 

  50. Tenenbaum S, Martin S, Fejeman N: Disease-modifying therapies in childhood and juvenile multiple sclerosis. Mult Scler 2001, 7:S57.

    Google Scholar 

  51. Adams AB, Tyor WR, Holden KR: Interferon beta-1b and childhood multiple sclerosis. Pediatr Neurol 1999, 21:481–483.

    Article  PubMed  CAS  Google Scholar 

  52. Weiner HL, Cohen JA: Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects. Mult Scler 2002, 8:142–154.

    Article  PubMed  CAS  Google Scholar 

  53. Khan OA, Zvartau-Hind M, Caon C, et al.: Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy. Mult Scler 2001, 7:185–188.

    PubMed  CAS  Google Scholar 

  54. Rammohan KW, Rosenberg JH, Lynn DJ, et al.: Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002, 72:179–183.

    Article  PubMed  CAS  Google Scholar 

  55. Cohen RA, Fisher M: Amantadine treatment of fatigue associated with multiple sclerosis. Arch Neurol 1989, 46:676–680.

    PubMed  CAS  Google Scholar 

  56. Rao SM: Neuropsychology of multiple sclerosis. Curr Opin Neurol 1995, 8:216–220.

    Article  PubMed  CAS  Google Scholar 

  57. Amato MP, Ponziani G, Siracusa G, Sorbi S: Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001, 58:1602–1606.

    Article  PubMed  CAS  Google Scholar 

  58. Banwell B, Anderson PE: Neuropsychological features of pediatric multiple sclerosis. Neurology 2002, 58:A173-A173.

    Google Scholar 

  59. Kalb RC, DiLorenzo TA, LaRocca NA, et al.: The impact of early onset multiple sclerosis on cognitive and social indices. Int J Mult Scler Care 1999, 1:2–17.

    Google Scholar 

  60. Sadovnick AD, Baird PA: The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology 1988, 38:990–991.

    PubMed  CAS  Google Scholar 

  61. Simone IL, Carrara D, Tortorella C, et al.: Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002, 59:1922–1928. authors compare retrospective pediatric and adult MS cohorts.

    PubMed  CAS  Google Scholar 

  62. Gusev E, Boiko A, Bikova O, et al.: The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver. Clin Neurol Neurosurg 2002, 104:203–207. Two cohorts of pediatric MS from two medical centers (in Vancouver and Moscow) are compared.

    Article  PubMed  Google Scholar 

  63. Boiko AN, Guseva ME, Guseva MR, et al.: Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children. J Neurovirol 2000, 6(suppl 2):S152-S155.

    PubMed  Google Scholar 

  64. Ghezzi A, Deplano V, Faroni J, et al.: Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler 1997, 3:43–46.

    Article  PubMed  CAS  Google Scholar 

  65. Selcen D, Anlar B, Renda Y: Multiple sclerosis in childhood: report of 16 cases. Eur Neurol 1996, 36:79–84.

    PubMed  CAS  Google Scholar 

  66. Cole GF, Stuart CA: A long perspective on childhood multiple sclerosis. Dev Med Child Neurol 1995, 37:661–666.

    Article  PubMed  CAS  Google Scholar 

  67. Guilhoto LM, Osorio CA, Machado LR, et al.: Pediatric multiple sclerosis report of 14 cases. Brain Dev 1995, 17:9–12.

    PubMed  CAS  Google Scholar 

  68. Sindern E, Haas J, Stark E, Wurster U: Early onset MS under the age of 16: clinical and paraclinical features. Acta Neurol Scand 1992, 86:280–284.

    Article  PubMed  CAS  Google Scholar 

  69. Hanefeld F, Bauer HJ, Christen HJ, et al.: Multiple sclerosis in childhood: report of 15 cases [see comments]. Brain Dev 1991, 13:410–416.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics (Neurology), The Hospital for Sick Children, 555 University Avenue, M5G 1X8, Toronto, ON, Canada

    Brenda L. Banwell MD

Authors
  1. Brenda L. Banwell MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banwell, B.L. Pediatric multiple sclerosis. Curr Neurol Neurosci Rep 4, 245–252 (2004). https://doi.org/10.1007/s11910-004-0045-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-004-0045-1

Keywords

Search

Navigation